Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens
Adam S Kibel1,2, Brant A Inman3, Russell K Pachynski4
1Affiliations of authors: Dana-Farber Cancer Institute, Boston, MA, USA.
Journal of the National Cancer Institute
|February 25, 2021
Summary
Sipuleucel-T immunotherapy directly kills prostate cancer cells expressing target antigens. This study provides the first visual evidence of T-cell mediated cancer cell lysis in patients treated with this prostate cancer therapy.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Sipuleucel-T is an autologous cellular immunotherapy approved for metastatic castration-resistant prostate cancer.
- It primes the immune system to target prostate acid phosphatase (PAP) on cancer cells, suggesting potential cell killing.
- Previous evidence for cell lysis was indirect.
Purpose of the Study:
- To provide direct visual evidence of T-cell mediated cancer cell lysis induced by Sipuleucel-T treatment.
- To analyze T-cell activity using advanced video technology on patient samples.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from subjects in the STAMP trial were utilized.
- CD8+ T cells were isolated as effector cells and co-cultured with autologous monocytes pulsed with control or target antigens.
- Differentially stained cells were video recorded during co-culture to observe interactions.
Main Results:
- Direct lysis of target cells expressing prostate cancer antigens (PAP or PSA) by T cells from Sipuleucel-T treated subjects was visualized.
- This study presents the first direct video evidence of Sipuleucel-T mediated cancer cell killing.
Conclusions:
- Sipuleucel-T treatment leads to direct cytotoxic activity of T cells against prostate cancer cells.
- Visual confirmation of cell lysis supports the mechanism of action for Sipuleucel-T in prostate cancer therapy.
Related Concept Videos
01:30Cancer Vaccines
621
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
621
01:27Tumor Immunotherapy
856
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
856
01:27Cytotoxic T Cells-mediated Immune Response
6.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.0K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K